Invest $225,000 in These 4 Dividend Stocks and Collect Quarterly Income in Retirement

Published November 22, 2026, 7:30am ET · 4 min read

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

An elderly couple sits at a wooden kitchen table. The man on the left, with white hair, wears a beige cardigan and holds a coffee mug, looking towards the woman. The woman on the right, also with white hair and glasses pushed up, wears a green shirt and rests her hands on a brown folder. A bowl of oranges and another steaming coffee mug are on the table. In the background, a bright kitchen with light-colored cabinets, a window looking out onto a green garden, and a kitchen sink are visible.
A couple enjoys a tranquil morning, reflecting the peace of mind that comes with a well-managed retirement portfolio providing steady quarterly income. © 24/7 Wall St.

Retirement changes the question a portfolio has to answer. While you’re working, the focus is on how big the balance can grow. Once the paychecks stop, the question becomes whether the portfolio can cover the electric bill, groceries and property taxes every three months without forcing you to sell shares at a bad moment.

Quarterly dividend payers match that schedule. Putting $56,250 into each of these four companies, or $225,000 in total, would produce roughly $5,800 a year in passive income. That works out to about $1,458.42 per quarter. The four come from banking, biotech, consumer staples and regulated utilities, and each one covers its dividend comfortably out of earnings. Yields are forward figures based on each company’s current annualized dividend and its November 20, 2026 closing price. Dividends can be cut, so none of this income is guaranteed.

JPMorgan Chase

JPMorgan Chase is the largest U.S. bank. It earns net interest income and fees through Chase consumer banking, the Commercial & Investment Bank and Asset & Wealth Management, which managed $5.14T in assets at the end of the second quarter. As a mature megabank, it returns surplus capital to shareholders through dividends and buybacks. A new $50B[1] repurchase program took effect on July 1, 2026.

The board raised the quarterly dividend to $1.65 from $1.50 in a declaration dated September 15, 2026. The new payment equals about 27% of second-quarter adjusted EPS of $6.14[1], and the CET1 ratio stood at 14.3%[2]. Earnings quality is the biggest worry. Reported EPS of $7.70[1] included a one-time $4.6B Visa gain, and the shares fell 10.3% in the week ended November 20. JPMorgan supplies about 20.5% of the group’s income.

Amgen

  • Stock #3: Amgen (NASDAQ:AMGN)
  • Yield: 2.31%
  • Shares for $56,250: 129.1
  • Annual Passive Income: ~$1,301.53

Amgen develops and sells biologic medicines. Its growth drivers include Repatha, whose third-quarter sales rose 37% to $1.085B, along with EVENITY and TEZSPIRE. As a mature large-cap drugmaker, it generates far more cash than it needs to reinvest. Third-quarter free cash flow was $3.65B.

The annualized $10.08 dividend equals about 44% of the low end of 2026 non-GAAP EPS guidance of $22.90 to $23.70[3]. In the records going back to 2011, the quarterly payout has climbed from $0.28 to $2.52 without a cut. The risks are $54.0B in debt and biosimilar competition, which drove Prolia sales down 45%. Amgen provides about 22.3% of the income.

Procter & Gamble

  • Stock #2: Procter & Gamble (NYSE:PG)
  • Yield: 2.57%
  • Shares for $56,250: 331.9
  • Annual Passive Income: ~$1,445.08

P&G sells Tide, Pampers, Gillette and Crest across five segments, and all five grew organically in the first quarter of fiscal 2027. Its everyday staples grow slowly but produce steady cash, with free cash flow of $15.835B[4] in fiscal 2026. The company plans to pay more than $10B[5] in dividends in fiscal 2027.

P&G has raised its dividend for 70[4] consecutive years and has paid one for 136 consecutive years. The annualized $4.354 payout is about 62% of the $7.00[5] midpoint of core EPS guidance. The risk is slowing profit growth. Barron’s reported on job cuts as earnings gains become harder to come by, and guidance includes about $1.4 billion in after-tax commodity cost pressures. P&G contributes about 24.8% of the income.

Evergy

  • Stock #1: Evergy (NASDAQ:EVRG)
  • Yield: 3.36%
  • Shares for $56,250: 654.6
  • Annual Passive Income: ~$1,891.80

Evergy is a regulated electric utility serving about 1.7 million customers in Kansas and Missouri. It earns a regulated return on the capital it invests. Because those cash flows are recovered through approved rates, they are predictable enough to support the highest yield of the four. Demand from data centers is rising, including a letter of intent with Digital Realty for a 1.4 GW[6] project.

Management raised the quarterly dividend 4%[6] to $0.7225, payable December 18, 2026. It also lifted 2026 adjusted EPS guidance to $4.35 to $4.50[6]. The annualized dividend equals about 66% of the low end of that range, which is above the long-term target of 50% to 60% and leaves a thinner cushion. The main risks are regulatory outcomes and heavy spending on new generation and transmission. Evergy delivers about 32.4% of the income.

Four Quarterly Paychecks, One Combined Total

Name Yield Annual Dividend Income Quarterly Income
JPMorgan Chase 2.12% $1,195.27 $298.82
Amgen 2.31% $1,301.53 $325.38
P&G 2.57% $1,445.08 $361.27
Evergy 3.36% $1,891.80 $472.95
Total 2.59% $5,833.68 $1,458.42

Together, these four positions generate $5,833.68 a year in passive income from a $225,000 investment, for a blended yield of 2.59%. Evergy contributes $1,891.80, P&G adds $1,445.08, Amgen supplies $1,301.53, and JPMorgan Chase completes the group with $1,195.27. Each of these companies can reduce or suspend its dividend, so the income depends on earnings holding up.

This kind of income also stays liquid. A rental property ties up a lump sum in a single asset, while a dividend portfolio can be trimmed a few shares at a time to cover a medical bill or rebalance. For retirees, that ability to turn income into cash on short notice matters as much as the yield, and the ideal is never having to sell at all (we laid out how to build a dividend ladder that lives off the checks without touching the shares in a free report here).

Contact [email protected] for any questions or corrections.

Lee Jackson

Lee Jackson has covered Wall Street analysts' equity and debt research and equity strategy daily for 24/7 Wall St. since 2012. His broad, diverse career, including a stint as creative services director at an NBC affiliate in Austin, Texas, gives him unique insight into the financial industry.

Lee Jackson's journey in the financial industry spans more than 30 years, including nearly two decades as an institutional equity salesperson at Bear Stearns, Lehman Brothers, and Morgan Stanley. His career spanned pivotal sell-side Wall Street events, from the dot-com rise and bubble to the Long-Term Capital Management debacle, 9/11, and the Great Recession of 2008. This reflects his resilience and adaptability amid market volatility.

Lee Jackson’s practical financial industry experience, gained through a career at some of the biggest banks and brokerage firms, is complemented by a lifetime of writing across various platforms. This unique combination allows him to shed light on the intricacies of Wall Street in a way only someone with deep insider experience and knowledge can. Moreover, his extensive network across Wall Street continues to provide direct access for him and 24/7 Wall St., a privilege few firms enjoy.

Since 2012, Jackson’s work for 24/7 Wall St. has been featured in Barron’s, Yahoo Finance, MarketWatch, Business Insider, TradingView, Real Money, The Street, Seeking Alpha, Benzinga, and other media outlets. He attended the prestigious Cranbrook Schools in Bloomfield Hills, Michigan, and has a degree in broadcasting from the Specs Howard School of Media Arts.

All articles →

Sources

  1. JP Morgan Chase & Form 8-K (Q2 FY2026)U.S. Securities and Exchange Commission
  2. JP Morgan Chase & Form 8-K (Q1 FY2026)U.S. Securities and Exchange Commission
  3. Amgen Form 8-K (Q2 FY2026)U.S. Securities and Exchange Commission
  4. P&G Form 8-K (Q4 FY2026)U.S. Securities and Exchange Commission
  5. P&G Form 8-K (Q1 FY2027)U.S. Securities and Exchange Commission
  6. Evergy Form 8-K (Q3 FY2026)U.S. Securities and Exchange Commission